nicorandil has been researched along with Electrocardiogram QT Prolonged in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Anai, R; Araki, M; Inoue, K; Kataoka, M; Miura, T; Naka, Y; Okabe, H; Setoyama, K; Sonoda, S | 1 |
| Akan, P; Akturk, G; Cilaker Micili, S; Ergur, BU; Gursoy Doruk, O; Hocaoglu, N; Kalkan, S; Karapinar, F; Sahin, O; Tuncok, Y | 1 |
| Ahmed, S; Akan, P; Akturk, G; Ergur, BU; Gursoy Doruk, O; Hocaoglu, N; Kalkan, S; Micili, SC | 1 |
| Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC | 1 |
| Denning, C; Dick, E; Matsa, E; Mellor, I; Rajamohan, D; Staniforth, A; Young, L | 1 |
| Hirayama, A; Kasamaki, Y; Kofune, M; Kunimoto, S; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I | 1 |
| Aizawa, Y; Chinushi, M; Chinushi, Y; Hosaka, Y; Kasai, H; Tagawa, M; Washizuka, T | 1 |
| Chang, IK; Chow, SN; Hsieh, FJ; Kau, ML; Ko, YH; Lee, CN; Shyu, MK | 1 |
| G, S; S, PC; S, RJ; Thomas, JM | 1 |
| Li, C; Liu, K; Liu, Y; Shi, G; Wang, H; Yang, Z | 1 |
| Shivkumar, K; Valderrabano, M | 1 |
| Hayashi, T; Nakayama, Y; Tsumura, K; Ueda, H; Yoshikawa, J; Yoshimaru, K | 1 |
| Aizawa, Y; Chinushi, M; Furushima, H; Inuzuka, H; Ojima, K; Shibata, A | 1 |
| Hata, Y; Mizuo, K; Morita, H; Ohe, T; Saito, D; Sato, T; Yamamoto, M; Yamanari, H | 1 |
| Aizawa, Y; Arita, M; Nakayama, T; Uchiyama, H; Yamaura, M | 1 |
| Aihara, N; Kamakura, S; Kurita, T; Matsuo, K; Shimizu, W; Shimomura, K; Suyama, K; Towbin, JA | 1 |
| Fujimoto, Y; Fukushima, KK; Morita, H; Ohe, T | 1 |
| Antzelevitch, C; Shimizu, W | 1 |
| Chinushi, M; Washizuka, T | 1 |
1 review(s) available for nicorandil and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
[Possibility of gene-specific treatment for hereditary arrhythmic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Humans; Ion Channels; Long QT Syndrome; Mexiletine; NAV1.4 Voltage-Gated Sodium Channel; Nicorandil; Sodium Channel Blockers; Sodium Channels; Ventricular Fibrillation | 2002 |
18 other study(ies) available for nicorandil and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Coronary Angiography; Coronary Stenosis; Drug Therapy, Combination; Electrocardiography; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Incidence; Long QT Syndrome; Male; Middle Aged; Nicorandil; Papaverine; Retrospective Studies; Safety; Tachycardia, Ventricular; Treatment Outcome; Vasodilator Agents | 2021 |
Effect of the selective mitochondrial KATP channel opener nicorandil on the QT prolongation and myocardial damage induced by amitriptyline in rats.
Topics: Amitriptyline; Animals; KATP Channels; Long QT Syndrome; Myocardium; Nicorandil; Rats | 2023 |
Effects of nicorandil on QT prolongation and myocardial damage caused by citalopram in rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Citalopram; Long QT Syndrome; Male; Nicorandil; Oxidants; Rats; Selective Serotonin Reuptake Inhibitors | 2023 |
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentiation; Cell Line; Cell Size; Cisapride; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Embryoid Bodies; Embryonic Stem Cells; Gene Expression Profiling; Genetic Predisposition to Disease; HEK293 Cells; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ion Channels; Kidney; Long QT Syndrome; Myocytes, Cardiac; Myofibrils; Nicorandil; Patch-Clamp Techniques; Quinazolines; Verapamil | 2013 |
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Chromosomes, Human, Pair 7; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Humans; Induced Pluripotent Stem Cells; Isoproterenol; Long QT Syndrome; Myocytes, Cardiac; Nicorandil; Point Mutation | 2011 |
Effect of the ATP-sensitive K⁺ channel opener nicorandil in a canine model of proarrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Electrocardiography; KATP Channels; Long QT Syndrome; Nicorandil; Pyrimidinones; Torsades de Pointes; Ventricular Premature Complexes | 2011 |
Triggers of ventricular tachyarrhythmias and therapeutic effects of nicorandil in canine models of LQT2 and LQT3 syndromes.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bradycardia; Disease Models, Animal; Dogs; Electrocardiography; Heart Block; Heart Conduction System; Infusions, Intravenous; Long QT Syndrome; Models, Cardiovascular; Nicorandil; Tachycardia; Treatment Outcome | 2002 |
Prenatal diagnosis and treatment of fetal long QT syndrome: a case report.
Topics: Adult; Bradycardia; Bundle-Branch Block; Electrocardiography; Female; Fetal Diseases; Heart Block; Heart Failure; Humans; Infant, Newborn; Lidocaine; Long QT Syndrome; Male; Nicorandil; Pregnancy; Pregnancy Trimester, Second; Propranolol; Tachycardia, Ventricular; Ultrasonography, Prenatal; Vasodilator Agents | 2002 |
Congenital Long QT Syndrome presenting as epilepsy.
Topics: Child; Diagnosis, Differential; Electrocardiography; Electrocardiography, Ambulatory; Follow-Up Studies; Humans; India; Long QT Syndrome; Male; Nicorandil; Risk Assessment; Seizures; Severity of Illness Index; Treatment Outcome | 2003 |
Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model.
Topics: Action Potentials; Animals; Chromans; Disease Models, Animal; Electrocardiography; Guinea Pigs; In Vitro Techniques; Long QT Syndrome; Nicorandil; Potassium Channel Blockers; Sulfonamides; Vasodilator Agents | 2004 |
Use of potassium channel openers for pharmacologic modulation of cardiac excitability.
Topics: Action Potentials; Animals; Humans; Long QT Syndrome; Nicorandil; Vasodilator Agents | 2004 |
Intravenous nicorandil can reduce QT dispersion and prevent bradyarrhythmia during percutaneous transluminal coronary angioplasty of the right coronary artery.
Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Bradycardia; Chi-Square Distribution; Cohort Studies; Coronary Vessels; Female; Humans; Infusions, Intravenous; Long QT Syndrome; Male; Middle Aged; Nicorandil | 2004 |
Nicorandil suppresses a hump on the monophasic action potential and torsade de pointes in a patient with idiopathic long QT syndrome.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Female; Humans; Long QT Syndrome; Niacinamide; Nicorandil; Torsades de Pointes | 1995 |
Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome.
Topics: Action Potentials; Adolescent; Anti-Arrhythmia Agents; Electrocardiography; Humans; Long QT Syndrome; Male; Niacinamide; Nicorandil; Potassium Channels; Syncope | 1995 |
Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Infusions, Intravenous; Long QT Syndrome; Male; Middle Aged; Niacinamide; Nicorandil; Potassium Channels; Torsades de Pointes | 1998 |
Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Child; Electrophysiology; Epinephrine; Female; Humans; Long QT Syndrome; Male; Middle Aged; Niacinamide; Nicorandil; Potassium Channels | 1998 |
Nicorandil abolished repolarisation alternans in a patient with idiopathic long QT syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Exercise Therapy; Female; Humans; Long QT Syndrome; Nicorandil; Syncope | 1999 |
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chromans; Cnidarian Venoms; Dogs; Electrocardiography; Electrophysiology; Heart; Isoproterenol; Long QT Syndrome; Nicorandil; Potassium Channels; Reaction Time; Sotalol; Sulfonamides; Torsades de Pointes | 2000 |